title: Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - Commentary.
authors.affiliation: Johns Hopkins University, Baltimore, MD, USA Emowry1@jhmi.edu.
authors.forename: Ellen M
authors.initials: EM
authors.lastname: Mowry
mesh_terms: D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells; D006801:Humans; D014182:Transplantation, Autologous